According to the Zhitong Finance App, Dongrui Pharmaceutical (02348) announced that on October 15, 2026, the company spent HK$191,900 to repurchase 196,000 shares at a repurchase price of HK$0.97-0.985 per share.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.